We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Proto Labs Inc | TG:PRZ | Tradegate | Ordinary Share |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.72 | -1.81% | 39.06 | 38.86 | 39.28 | 39.38 | 39.12 | 39.38 | 286 | 22:50:18 |
RNS Number:3051S Prezzo PLC 20 November 2003 PREZZO PLC PLACING OF 4,135,625 NEW ORDINARY SHARES Prezzo plc ("Prezzo" or "the Company") is pleased to announce that it has raised approximately #2.7million, before expenses, through a placing ("the Placing"), predominantly with existing shareholders of 4,135,625 new ordinary shares of 20p each ("New Shares") at a price of 65 pence per share. The Placing is conditional upon admission of the New Shares to trading on AIM. The net proceeds from the Placing will be used by the Company to continue the expansion of its restaurant chains, specifically for the purchase and fit out of two freehold sites in Brentwood and Norwich. The Directors anticipate that these two purchases, together with commitments for a further seven restaurants secured following the Company's #6.0 million placing in May 2003, will bring the aggregate number of sites owned or leased to 34 at the end of 2003, of which 26 are expected to be open for business at the year end. Further restaurant openings are scheduled for the first half of 2004. Certain of the directors of the Company ("Directors") have subscribed, in aggregate, for 408,000 New Shares through the Placing and following these subscriptions, they will have the following beneficial interests: Name Subscription Number of Ordinary Percentage of enlarged issued Shares after the share capital after the Placing Placing Jonathan 385,000 6,968,333 15.44 Kaye Michael 23,000 204,667 0.45 Carlton In addition, the Company was today notified that Phillip Kaye, a consultant to the Company, subscribed for 2,533,577 New Shares through the Placing. Following this subscription, Phillip Kaye has a beneficial interest in 23,123,577 ordinary shares, representing 51.25 per cent. of the Company's enlarged issued ordinary share capital. As Jonathan Kaye and Michael Carlton are Directors and Phillip Kaye is a substantial shareholder of the Company, the participation by them in the Placing constitutes a related party transaction (as defined in the AIM Rules). John Lederer, the Non-executive Director who is not participating in the Placing, having consulted with Evolution Beeson Gregory Limited, Prezzo's nominated adviser, considers that the terms of the transaction are fair and reasonable insofar as the Company's shareholders are concerned. Application will be made for the New Shares to be admitted to trading on AIM and dealings are expected to commence on 26 November 2003. 20 November 2003 This information is provided by RNS The company news service from the London Stock Exchange END RDSLBLFLXFBXFBD
1 Year Proto Labs Chart |
1 Month Proto Labs Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions